Operating Lease, Right-of-Use Asset in USD of NovoCure Ltd from Q4 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
NovoCure Ltd quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2018 to Q3 2025.
  • NovoCure Ltd Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $48,402,000, a 70.9% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

NovoCure Ltd Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $48,402,000 +$20,072,000 +71% 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 $48,089,000 +$19,013,000 +65% 30 Jun 2025 10-Q 24 Jul 2025 2025 Q2
Q1 2025 $48,511,000 +$15,517,000 +47% 31 Mar 2025 10-Q 24 Apr 2025 2025 Q1
Q4 2024 $27,120,000 -$7,715,000 -22% 31 Dec 2024 10-Q 30 Oct 2025 2025 Q3
Q3 2024 $28,330,000 -$684,000 -2.4% 30 Sep 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 $29,076,000 +$2,798,000 +11% 30 Jun 2024 10-Q 25 Jul 2024 2024 Q2
Q1 2024 $32,994,000 +$7,465,000 +29% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 $34,835,000 +$11,239,000 +48% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $29,014,000 +$9,609,000 +50% 30 Sep 2023 10-Q 26 Oct 2023 2023 Q3
Q2 2023 $26,278,000 +$7,997,000 +44% 30 Jun 2023 10-Q 27 Jul 2023 2023 Q2
Q1 2023 $25,529,000 +$5,592,000 +28% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $23,596,000 +$5,329,000 +29% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 $19,405,000 +$2,945,000 +18% 30 Sep 2022 10-Q 27 Oct 2022 2022 Q3
Q2 2022 $18,281,000 +$1,317,000 +7.8% 30 Jun 2022 10-Q 28 Jul 2022 2022 Q2
Q1 2022 $19,937,000 +$2,196,000 +12% 31 Mar 2022 10-Q 28 Apr 2022 2022 Q1
Q4 2021 $18,267,000 -$742,000 -3.9% 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q3 2021 $16,460,000 -$662,000 -3.9% 30 Sep 2021 10-Q 28 Oct 2021 2021 Q3
Q2 2021 $16,964,000 -$465,000 -2.7% 30 Jun 2021 10-Q 29 Jul 2021 2021 Q2
Q1 2021 $17,741,000 +$540,000 +3.1% 31 Mar 2021 10-Q 29 Apr 2021 2021 Q1
Q4 2020 $19,009,000 +$1,438,000 +8.2% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 $17,122,000 +$2,487,000 +17% 30 Sep 2020 10-Q 29 Oct 2020 2020 Q3
Q2 2020 $17,429,000 +$2,770,000 +19% 30 Jun 2020 10-Q/A 02 Oct 2020 2020 Q2
Q1 2020 $17,201,000 +$3,281,000 +24% 31 Mar 2020 10-Q/A 02 Oct 2020 2020 Q1
Q4 2019 $17,571,000 +$17,571,000 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $14,635,000 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 $14,659,000 30 Jun 2019 10-Q 25 Jul 2019 2019 Q2
Q1 2019 $13,920,000 31 Mar 2019 10-Q 02 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-Q 31 Oct 2019 2019 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.